242 related articles for article (PubMed ID: 12648456)
41. Transient role for CD1d-restricted natural killer T cells in the formation of atherosclerotic lesions.
Aslanian AM; Chapman HA; Charo IF
Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):628-32. PubMed ID: 15591216
[TBL] [Abstract][Full Text] [Related]
42. Characterization of NKT cells in human peripheral blood and decidual lymphocytes.
Tsuda H; Sakai M; Michimata T; Tanebe K; Hayakawa S; Saito S
Am J Reprod Immunol; 2001 May; 45(5):295-302. PubMed ID: 11432404
[TBL] [Abstract][Full Text] [Related]
43. Immediate antigen-specific effector functions by TCR-transgenic CD8+ NKT cells.
Wingender G; Berg M; Jüngerkes F; Diehl L; Sullivan BA; Kronenberg M; Limmer A; Knolle PA
Eur J Immunol; 2006 Mar; 36(3):570-82. PubMed ID: 16506291
[TBL] [Abstract][Full Text] [Related]
44. [A specific ligand of V alpha 14 NKT cells and its presentation].
Harada M; Taniguchi M
Tanpakushitsu Kakusan Koso; 2003 Jun; 48(8 Suppl):1126-32. PubMed ID: 12807019
[No Abstract] [Full Text] [Related]
45. [The regulatory role of V alpha 14 NKT cells in innate and acquired immune response].
Harada M; Taniguchi M
Tanpakushitsu Kakusan Koso; 2002 Dec; 47(16 Suppl):2109-16. PubMed ID: 12518422
[No Abstract] [Full Text] [Related]
46. Regulation by Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 of alpha-galactosylceramide-induced antimetastatic activity and Th1 and Th2 responses of NKT cells.
Okajo J; Kaneko Y; Murata Y; Tomizawa T; Okuzawa C; Saito Y; Kaneko Y; Ishikawa-Sekigami T; Okazawa H; Ohnishi H; Matozaki T; Nojima Y
J Immunol; 2007 May; 178(10):6164-72. PubMed ID: 17475843
[TBL] [Abstract][Full Text] [Related]
47. Contribution of CD1d-unrestricted hepatic DX5+ NKT cells to liver injury in Plasmodium berghei-parasitized erythrocyte-injected mice.
Adachi K; Tsutsui H; Seki E; Nakano H; Takeda K; Okumura K; Van Kaer L; Nakanishi K
Int Immunol; 2004 Jun; 16(6):787-98. PubMed ID: 15096477
[TBL] [Abstract][Full Text] [Related]
48. The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR.
Pyz E; Naidenko O; Miyake S; Yamamura T; Berberich I; Cardell S; Kronenberg M; Herrmann T
J Immunol; 2006 Jun; 176(12):7447-55. PubMed ID: 16751390
[TBL] [Abstract][Full Text] [Related]
49. The role of CD1d-restricted NK T lymphocytes in the immune response to oral infection with Salmonella typhimurium.
Berntman E; Rolf J; Johansson C; Anderson P; Cardell SL
Eur J Immunol; 2005 Jul; 35(7):2100-9. PubMed ID: 15940666
[TBL] [Abstract][Full Text] [Related]
50. Immunology. T before NK.
MacDonald HR
Science; 2002 Apr; 296(5567):481-2. PubMed ID: 11964466
[No Abstract] [Full Text] [Related]
51. CD1d-mediated antigen presentation to natural killer T (NKT) cells.
Brutkiewicz RR; Lin Y; Cho S; Hwang YK; Sriram V; Roberts TJ
Crit Rev Immunol; 2003; 23(5-6):403-19. PubMed ID: 15030309
[TBL] [Abstract][Full Text] [Related]
52. CD161 (NKR-P1A) costimulation of CD1d-dependent activation of human T cells expressing invariant V alpha 24 J alpha Q T cell receptor alpha chains.
Exley M; Porcelli S; Furman M; Garcia J; Balk S
J Exp Med; 1998 Sep; 188(5):867-76. PubMed ID: 9730888
[TBL] [Abstract][Full Text] [Related]
53. Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells.
Metelitsa LS; Naidenko OV; Kant A; Wu HW; Loza MJ; Perussia B; Kronenberg M; Seeger RC
J Immunol; 2001 Sep; 167(6):3114-22. PubMed ID: 11544296
[TBL] [Abstract][Full Text] [Related]
54. Rapid development of a gamma interferon-secreting glycolipid/CD1d-specific Valpha14+ NK1.1- T-cell subset after bacterial infection.
Emoto M; Yoshizawa I; Emoto Y; Miamoto M; Hurwitz R; Kaufmann SH
Infect Immun; 2006 Oct; 74(10):5903-13. PubMed ID: 16988270
[TBL] [Abstract][Full Text] [Related]
55. Age-associated augmentation of the synthetic ligand- mediated function of mouse NK1.1 ag(+) T cells: their cytokine production and hepatotoxicity in vivo and in vitro.
Inui T; Nakagawa R; Ohkura S; Habu Y; Koike Y; Motoki K; Kuranaga N; Fukasawa M; Shinomiya N; Seki S
J Immunol; 2002 Dec; 169(11):6127-32. PubMed ID: 12444115
[TBL] [Abstract][Full Text] [Related]
56. CD1d-restricted NKT cells contribute to the age-associated decline of T cell immunity.
Faunce DE; Palmer JL; Paskowicz KK; Witte PL; Kovacs EJ
J Immunol; 2005 Sep; 175(5):3102-9. PubMed ID: 16116199
[TBL] [Abstract][Full Text] [Related]
57. Cutting edge: the IgG response to the circumsporozoite protein is MHC class II-dependent and CD1d-independent: exploring the role of GPIs in NK T cell activation and antimalarial responses.
Molano A; Park SH; Chiu YH; Nosseir S; Bendelac A; Tsuji M
J Immunol; 2000 May; 164(10):5005-9. PubMed ID: 10799852
[TBL] [Abstract][Full Text] [Related]
58. Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis.
Fuss IJ; Heller F; Boirivant M; Leon F; Yoshida M; Fichtner-Feigl S; Yang Z; Exley M; Kitani A; Blumberg RS; Mannon P; Strober W
J Clin Invest; 2004 May; 113(10):1490-7. PubMed ID: 15146247
[TBL] [Abstract][Full Text] [Related]
59. Lipid antigen presentation in the immune system: lessons learned from CD1d knockout mice.
Hong S; Scherer DC; Singh N; Mendiratta SK; Serizawa I; Koezuka Y; Van Kaer L
Immunol Rev; 1999 Jun; 169():31-44. PubMed ID: 10450506
[TBL] [Abstract][Full Text] [Related]
60. Phenotypical and functional alterations during the expansion phase of invariant Valpha14 natural killer T (Valpha14i NKT) cells in mice primed with alpha-galactosylceramide.
Ikarashi Y; Iizuka A; Koshidaka Y; Heike Y; Takaue Y; Yoshida M; Kronenberg M; Wakasugi H
Immunology; 2005 Sep; 116(1):30-7. PubMed ID: 16108815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
